Zevra Therapeutics’ MIPLYFFA receives FDA approval as first treatment for Niemann-Pick disease
Zevra Therapeutics Inc. has announced U.S. Food and Drug Administration (FDA) approval of MIPLYFFA (arimoclomol), a capsule-based treatment for Niemann-Pick disease type C (NPC), a ... Read More
Amplia Therapeutics secures FDA fast track status for narmafotinib in pancreatic cancer, stock surges
Amplia Therapeutics Limited (ASX: ATX) has announced that its Focal Adhesion Kinase (FAK) inhibitor, narmafotinib, has been granted Fast Track Designation by the United States ... Read More
KEC International secures Rs 1,423cr Saudi contract, shares surge over 6%
KEC International Ltd, a leading global infrastructure Engineering, Procurement, and Construction (EPC) company under the RPG Group, saw its stock surge significantly, reaching a 52-week ... Read More
Elevation Gold Mining stock jumps 7% after TSX approval for Hercules Property sale
Elevation Gold Mining Corporation (TSXV: ELVT.H) has announced the final approval from the TSX Venture Exchange for the sale of its Hercules Property, located in ... Read More
U.S. Silica Holdings, Inc. to be acquired by Apollo Funds for $1.85bn
In a major development in the industrial minerals sector, U.S. Silica Holdings, Inc. (NYSE: SLCA), a diversified industrial minerals company and a leader in last-mile ... Read More